Mark C. Leavitt
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2003First federal award
$1.6MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2008 | NIH | SBIR/STTR Phase II Enhancement of the glycosylation machinery of the hen bioreactor | $370K | SYNAGEVA BIOPHARMA CORP. |
| Jul 15, 2008 | NIH | SBIR/STTR Phase II Enhancement of the glycosylation machinery of the hen bioreactor | $378K | SYNAGEVA BIOPHARMA CORP. |
| May 1, 2003 | NIH | SBIR/STTR Phase II Oviduct locus BACs for expression of bio-therapeutics | $346K | SYNAGEVA BIOPHARMA CORP. |
| May 1, 2003 | NIH | SBIR/STTR Phase II Oviduct locus BACs for expression of bio-therapeutics | $382K | SYNAGEVA BIOPHARMA CORP. |
| May 1, 2003 | NIH | SBIR/STTR Phase I Ovalbumin locus BACs for expression of biotherapeutics | $81K | SYNAGEVA BIOPHARMA CORP. |
Peer ranks
Federal funding#270
Awards as PI#156
Patents#27
Companies
- SYNAGEVA BIOPHARMA CORP.Linked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.